CpG DNA switches on Th1 immunity and modulates antigen-presenting cell function
RS Chu, D Askew, CV Harding - Immunobiology of bacterial CpG-DNA, 2000 - Springer
DNA containing CpG motifs, which are present in bacterial DNA but suppressed in
mammalian DNA, can stimulate immune cells and modulate immune responses. A CpG …
mammalian DNA, can stimulate immune cells and modulate immune responses. A CpG …
Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer
J Scheiermann, DM Klinman - Vaccine, 2014 - Elsevier
Synthetic oligonucleotides (ODN) that express unmethylated “CpG motifs” trigger cells that
express Toll-like receptor 9. In humans this includes plasmacytoid dendritic cells and B cells …
express Toll-like receptor 9. In humans this includes plasmacytoid dendritic cells and B cells …
Lack of immune stimulation by immobilized CpG-oligodeoxynucleotide
L Manzel, DE MacFarlane - Antisense and Nucleic Acid Drug …, 1999 - liebertpub.com
Selected phosphorothioate oligodeoxynucleotides containing CpG (CpG-ODN) activate
immune responses, including B-cell proliferation and cytokine production. The mechanism …
immune responses, including B-cell proliferation and cytokine production. The mechanism …
CpG DNA as a Th1 trigger
K Heeg, S Zimmermann - International archives of allergy and …, 2000 - karger.com
Over the last few years, it has been recognized that along with structural components and
products of bacteria, bacterial DNA is also capable of signaling infectious danger to cells of …
products of bacteria, bacterial DNA is also capable of signaling infectious danger to cells of …
Structural requirements for uptake and recognition of CpG oligonucleotides
K Heeg, A Dalpke, M Peter, S Zimmermann - International Journal of …, 2008 - Elsevier
Recognition of infectious danger by innate immune cells is a fundamental requirement to
directly combat infections and to activate the adaptive immune response of T and B cells …
directly combat infections and to activate the adaptive immune response of T and B cells …
CpG oligodeoxynucleotides for anticancer monotherapy from preclinical stages to clinical trials
CpG oligodeoxynucleotides (CpG ODNs), the artificial versions of unmethylated CpG motifs
that were originally discovered in bacterial DNA, are demonstrated not only as potent …
that were originally discovered in bacterial DNA, are demonstrated not only as potent …
Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs
AM Krieg, T Wu, R Weeratna, SM Efler… - Proceedings of the …, 1998 - National Acad Sciences
Unmethylated CpG dinucleotides in particular base contexts (CpG-S motifs) are relatively
common in bacterial DNA but are rare in vertebrate DNA. B cells and monocytes have the …
common in bacterial DNA but are rare in vertebrate DNA. B cells and monocytes have the …
The role of bacterial DNA containing CpG motifs in diseases
J Zhou, GM Deng - Journal of Leucocyte Biology, 2021 - academic.oup.com
Bacterial DNA containing unmethylated CpG motifs can activate immune cells to release
proinflammatory cytokines. Here, the role of bacterial DNA containing CpG motifs in …
proinflammatory cytokines. Here, the role of bacterial DNA containing CpG motifs in …
An immunomodulatory GpG oligonucleotide for the treatment of autoimmunity via the innate and adaptive immune systems
PP Ho, P Fontoura, PJ Ruiz, L Steinman… - The Journal of …, 2003 - journals.aai.org
Bacterial DNA and immunostimulatory CpG oligodeoxynucleotides (ODNs) activate the
innate immune system to produce proinflammatory cytokines. Shown to be potent Th1-like …
innate immune system to produce proinflammatory cytokines. Shown to be potent Th1-like …
Combinations and methods of using an immunomodulatory oligodeoxynucleotide
JUB Jungnelius, DRJ Readett… - US Patent App. 12/093,265, 2009 - Google Patents
BACKGROUND 0002. A traditional approach to treating cancer is to target the tumor itself
with therapy. An alternative approach to can cer therapy is to target the immune system …
with therapy. An alternative approach to can cer therapy is to target the immune system …